Alan Brochstein is the founding partner of New Cannabis Ventures, a leading provider of information relevant to the cannabis industry created in 2015.
As a leading financial analyst within the world of cannabis for nearly a decade, Brochstein has become a highly regarded expert in the burgeoning space. Brochstein spent decades in the investment industry as a portfolio manager before changing his focus to the cannabis industry.
Listen to the interview:
In this episode of Opto Sessions, Brochstein looks to answer one of the burning questions in the mind of investors interested in the space: exactly, how much potential is there in the cannabis industry?
“The good news is that you can just start with the realisation that there’s a massive illegal market or illicit market. Cannabis is already a very widely consumed product around the world,” Brochstein explains.
“The good news is that you can just start with the realisation that there’s a massive illegal market or illicit market. Cannabis is already a very widely consumed product around the world”
Brochstein notes that hundreds of billions of dollars each year are spent on cannabis, but that the legal market is a very small part of that.
Therein lies its potential Brochstein says. The opportunity comes from being able to take all those people that are buying or using an unregulated product, and then being able to provide something that is, in theory, safer and more convenient.
“But that’s only the beginning because there’s really the whole idea of being able to create new products within a legal framework,” Brochstein continues.
“In the illicit market, there’s really not a big advantage to doing R&D. You can’t really get patents, you can’t really advertise what you’re doing. But in the legal market, you have the potential to create new products, especially pharmaceutical products,” Brochstein says.
“In the illicit market, there’s really not a big advantage to doing R&D. You can’t really get patents, you can’t really advertise what you’re doing. But in the legal market, you have the potential to create new products, especially pharmaceutical products”
He explains that there is a huge market for products such as over-the-counter prescription cannabis medicines, which are already emerging. He also points to companies working with CBD within their products.
“Then there’s a whole new category or two between health and wellness and pharmaceuticals — they can make the market even bigger,” Brochstein considers.
To hear more from Brochstein, including some misconceptions surrounding commonly held cannabis stocks, listen to the full episode on Opto Sessions.
Or for more ways to listen:
Disclaimer Past performance is not a reliable indicator of future results.
CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.
The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.
CMC Markets does not endorse or offer opinion on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein.
*Tax treatment depends on individual circumstances and can change or may differ in a jurisdiction other than the UK.